Company Profile
Agilent Technologies Stock Price, News & Analysis
- Ticker:
- A
- Exchange:
- NYSE
- Sector:
- MedTech
- Location:
- United States
Stock performance
141.34 USD (+0.16%)
Close
Last updated: August 6, 2026
38.1B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, A was little changed and closed at $141.34. No new same-company headline was identified in the current news window.
Company overview
Business overview
Agilent Technologies is a life sciences, diagnostics, and analytical instrumentation company that supports pharmaceutical research, clinical labs, and applied markets. Its role is foundational to the broader biotech ecosystem, even though it is not a drug company.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NYSE, Agilent has a global footprint in lab equipment and diagnostics. It sits in life sciences tools and diagnostics rather than therapeutic biotechnology.
Business Model Characteristics
The business is driven by instruments, consumables, services, and workflow solutions used in research and diagnostics. Investors watch lab demand, biopharma spending, and the health of research and diagnostic budgets because they affect recurring usage.
Position Within the Biotechnology Landscape
Agilent is part of the biotech infrastructure layer rather than the therapeutic layer. It usually moves on research spending and lab activity, not on approval or clinical-trial events.
Future catalysts
Agilent’s catalysts are biopharma spending recovery, lab-instrument demand, and diagnostic / assay growth in a still-choppy funding environment. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Agilent Technologies (A)?
Agilent Technologies (A) most recently closed at 141.34 USD, a +0.16% move versus the previous session.
What is the market cap of Agilent Technologies (A)?
Agilent Technologies currently has a market capitalization of 38.1B USD on BioPharmSignal.
What does Agilent Technologies do?
Agilent Technologies is a life sciences, diagnostics, and analytical instrumentation company that supports pharmaceutical research, clinical labs, and applied markets. Its role is foundational to the broader biotech ecosystem, even though it is not a drug company.
On which exchange is A stock listed?
Agilent Technologies (A) is associated with NYSE, United States, MedTech.
What is Agilent?
Agilent’s catalysts are biopharma spending recovery, lab-instrument demand, and diagnostic / assay growth in a still-choppy funding environment.
Which conditions is Agilent Technologies targeting with Agilent?
Agilent’s catalysts are biopharma spending recovery, lab-instrument demand, and diagnostic / assay growth in a still-choppy funding environment.
How does Agilent Technologies describe recent progress with Agilent?
Agilent’s catalysts are biopharma spending recovery, lab-instrument demand, and diagnostic / assay growth in a still-choppy funding environment.
What is Technologies?
Agilent Technologies is a life sciences, diagnostics, and analytical instrumentation company that supports pharmaceutical research, clinical labs, and applied markets.